Montauk RRG
Major Rating Factors:
Weak overall results on stability tests (0.0 on a scale of 0 to 10) including weak risk adjusted capital in prior years, weak risk diversification and negative cash flow from operations for 2024. The largest net exposure for one risk is excessive at 64.1% of capital. Fair long-term capitalization index (4.2) based on fair current risk adjusted capital (severe loss scenarios), although results have slipped from the good range during the last year. History of adequate reserve strength (6.0) as reserves have been consistently at an acceptable level.
Other Rating Factors:
Good profitability index (4.9) with operating losses during 2022 and the first three months of 2025. Return on equity has been fair, averaging 8.0% over the past five years. Good liquidity (7.0) with sufficient resources (cash flows and marketable investments) to handle a spike in claims.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
G - Fast asset or premium growth.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (95.4%), other (4.6%)
Licensed in:
VT
Principal Investments:
Investment grade bonds (65.4%), common stock (26.9%), cash (3.8%), other (3.8%)
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
463 Mountain View Drive
Colchester, VT 05446
Colchester, VT 05446
Phone Number
(802) 864-5599
NAIC Number
16218
Website
--
Largest Affiliates
No affiliate information available.